Contemporary Pediatrics
@contemppeds.bsky.social
Practical Information for Today's Pediatrician
Thank you for sharing!
December 10, 2025 at 8:36 PM
Thank you for sharing!
FULL DETAILS: www.contemporarypediatrics.com/view/fda-acc...
FDA accepts roflumilast cream 0.3% sNDA to treat plaque psoriasis in children 2 to 5 years | Contemporary Pediatrics
The target action date for roflumilast cream 0.3% for plaque psoriasis in children 2 to 5 years is set for June 29, 2026.
www.contemporarypediatrics.com
November 17, 2025 at 3:04 PM
FULL DETAILS: www.contemporarypediatrics.com/view/fda-acc...
For full approval details, read our full article: www.contemporarypediatrics.com/view/fda-exp...
#medsky #pedsky
#medsky #pedsky
FDA expands adalimumab-aaty's pediatric indications to include hidradenitis suppurativa, uveitis
Indication expansions include hidradenitis suppurativa for patients 12 years and up, as well as for patients with uveitis aged 2 years and older.
www.contemporarypediatrics.com
October 17, 2025 at 2:31 PM
For full approval details, read our full article: www.contemporarypediatrics.com/view/fda-exp...
#medsky #pedsky
#medsky #pedsky